HBV Citations List: April 2025
Literature Citations
1. Development of Sulfamoylbenzamide-based Capsid Assembly Modulators for Hepatitis B Virus Capsid Assembly.Abbas, S.A., H.M. Cha, S. Nayak, S. Ahn, J. Gowda, I. Lieknina, A. Dislers, I.S. Kim, I. Jo, M. Kim, H. Kim, C. Ko, and S.B. Han. European Journal of Medicinal Chemistry, 2025. 290. PMID[40184774].
[PubMed]. HBV_04_2025.
2. Rapavir, a Novel Inhibitor of Sodium Taurocholate Cotransporting Polypeptide, Potently Blocks Hepatitis B Virus Entry. He, J., H. Yu, K. Song, A. Huang, Y. Dang, J. Chen, and Z. Guo. Signal Transduction and Targeted Therapy, 2025. 10(1): 130. PMID[40263266] PMCID[12015363].
[PubMed]. HBV_04_2025.
3. Sirtuin 2 Inhibitor AGK2 Exerts Antiviral Effects by Inducing Epigenetic Suppression of Hepatitis B Virus Covalently Closed Circular DNA Through Recruitment of Repressive Histone Lysine Methyltransferases and Reduction of cccDNA. Kim, J., J. Ha, C. Song, M.A. Sajjad, F. Kalsoom, H. Kwon, J. Park, S. Park, and K. Kim. Frontiers in Cellular and Infection Microbiology, 2025. 15: 1537929. PMID[40270769] PMCID[12014779].
[PubMed]. HBV_04_2025.
4. Anti-HBV Activity of (R)-Gentiandiol, a Metabolite of Swertiamarin, in Transgenic Mice: Insights from Non-targeted Serum Metabolomics.Sun, Y., S. Tang, Y. Xu, H. Li, P. Li, M. Hattori, H. Zhang, X. Li, and Z. Wang. Bioorganic Medicinal Chemistry, 2025. 121: 118128. PMID[40024145].
[PubMed]. HBV_04_2025.
Patent Citations
5. Phosphonate prodrugs and use thereof. Edagwa, B. Patent. 2025. WO2024-US482592025072232: 109 pp.
[Patent]. HBV_04_2025.
6. Synthesis of Flex-nucleoside analogs for treating or preventing viral infections. Radtke, K.L. Patent. 2025. US2024-97707720250109162: 59 pp.
[Patent]. HBV_04_2025.